Convection-enhanced drug delivery to the brain

Neuromethods

Volumn 45, Issue , 2010, Pages 291-318

  Ding, Dale ^a   Kanaly, Charles W ^b   Brady, Martin L ^c   Mittermeyer, Stephan ^d   Raghavan, Raghu ^c   Sampson, John H ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE UNIVERSITY   (United States)

^c Therataxis LLC   (United States)

^d BRAINLAB AG   (Germany)

Author keywords

Brain; Convection enhanced delivery; Drug delivery; Glioblastoma

Indexed keywords

ALBUMIN CONJUGATE; ANTINEOPLASTIC AGENT; AP 12009; CARMUSTINE; CINTREDEKIN BESUDOTOX; COTARA; CYTOTOXIN; GADOLINIUM; GADOLINIUM PENTETATE; GANCICLOVIR; INTERLEUKIN 4; IOPANOIC ACID; NBI 3001; PACLITAXEL; PSEUDOMONAS EXOTOXIN; TEMOZOLOMIDE; THYMIDINE KINASE; TP 38; TRANSFERRIN; TRANSFERRIN CRM107; TRANSMID; UNCLASSIFIED DRUG;

ABSENCE OF SIDE EFFECTS; ANTINEOPLASTIC ACTIVITY; BACTERIAL INFECTION; BLOOD BRAIN BARRIER; BRAIN EDEMA; BRAIN VENTRICLE; CANCER SURVIVAL; CATHETER; CLINICAL TRIAL; COMPUTER PROGRAM; CONTRAST ENHANCEMENT; CONVECTION ENHANCED DELIVERY; CONVULSION; DIFFUSION WEIGHTED IMAGING; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG DOSE ESCALATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; EXTERNAL BEAM RADIOTHERAPY; FLUID TRANSPORT; GLIOBLASTOMA; GLIOMA; HEADACHE; HEMIPARESIS; HUMAN; INTRACEREBRAL DRUG ADMINISTRATION; LIPOSOMAL DELIVERY; LOCAL THERAPY; MENINGITIS; MULTIPLE CYCLE TREATMENT; NEUROIMAGING; NEUROTOXICITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARENCHYMA; PRIORITY JOURNAL; REVIEW; SEIZURE; SUBARACHNOID SPACE; THERMODYNAMICS; WEAKNESS;

EID: 73849116396     PISSN: 08932336     EISSN: 19406045     Source Type: Book Series    
DOI: 10.1007/978-1-60761-529-3_15     Document Type: Review

References (88)

1. Primary brain tumors in the United States statistical report. Central Brain Tumor Registry of the United States; 2007-2008.
2. Stupp, R., Mason, W. P., van den Bent, M. J. et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med (Mar 10), 352(10), 987-996
3. Hegi, M. E., Diserens, A. C., Gorlia, T. et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med (Mar 10), 352(10), 997-1003.
4. Bobo, R. H., Laske, D. W., Akbasak, A., Morrison, P. F., Dedrick, R. L., and Oldfield, E. H. (1994) Convection-enhanced delivery of macromolecules in the brain. Proc Natl Acad Sci U S A (Mar 15), 91(6), 2076-2080
5. Vogelbaum, M. A. (2005) Convection enhanced delivery for the treatment of malignant gliomas: symposium review. J Neurooncol (May) 73(1), 57-69.
6. Bankiewicz, K. S., Eberling, J. L., Kohutnicka, M. et al (2000) Convection-enhanced delivery of AAV vector in parkinsonian monkeys; in vivo detection of gene expression and restoration of dopaminergic function using pro-drug approach. Exp Neurol (Jul) 164(1), 2-14.
7. Oiwa, Y., Sanchez-Pernaute, R., Harvey-White, J., and Bankiewicz, K. S. (2003) Progressive and extensive dopaminergic degeneration induced by convection-enhanced delivery of 6-hydroxydopamine into the rat striatum: a novel rodent model of Parkinson disease. J Neurosurg (Jan) 98(1), 136-144
8. Zirzow, G. C., Sanchez, O. A., Murray, G. J., Brady, R. O., and Oldfield, E. H. (1999) Delivery, distribution, and neuronal uptake of exogenous mannose-terminal glucocerebrosidase in the intact rat brain. Neurochem Res (Feb) 24(2), 301-305
9. Lonser, R. R., Walbridge, S., Murray, G. J. et al (2005) Convection perfusion of glucocerebrosidase for neuronopathic Gaucher's disease. Ann Neurol (Apr) 57(4), 542-548
10. Lonser, R. R., Schiffman, R., Robison, R. A. et al (2007) Image-guided, direct convective delivery of glucocerebrosidase for neuronopathic Gaucher disease. Neurology (Jan 23) 68(4), 254-261
11. O'Connor, W. M., Davidson, B. L., Kaplitt, M. G. et al. (1997) Adenovirus vectormediated gene transfer into human epileptogenic brain slices: prospects for gene therapy in epilepsy. Exp Neurol (Nov), 148(1), 167-178
12. Fisher, R. S. and Ho, J. (2002) Potential new methods for antiepileptic drug delivery. CNS Drugs 16(9), 579-593
13. Tenenbaum, L., Chtarto, A., Lehtonen, E., Velu, T., Brotchi, J., and Levivier, M. (2004) Recombinant AAV-mediated gene delivery to the central nervous system. J Gene Med (Feb) 6(Suppl 1), S212-S22.
14. Fisher, R. S. and Chen, D. K. (2006) New routes for delivery of anti-epileptic medications. Acta Neurol Taiwan (Dec) 15(4), 225-231
15. Vogelbaum, M. A. (2007) Convection enhanced delivery for treating brain tumors and selected neurological disorders: symposium review. J Neurooncol (May) 83(1), 97-109.
16. Hornung, U. (ed) (1997) Homogenization and Porous Media. Springer, New York.
17. Raghavan, R., Brady, M. L., Rodriguez-Ponce, M. I., Hartlep, A., Pedain, C., and Sampson, J. H. (2006) Convectionenhanced delivery of therapeutics for brain disease, and its optimization. Neurosurg Focus 20(4), E12.
18. Saito, R., Krauze, M. T., Noble, C. O. et al (2006) Tissue affinity of the infusate affects the distribution volume during convectionenhanced delivery into rodent brains: implications for local drug delivery. J Neurosci Meth (Jun 30) 154(1-2), 225-232
19. Guarnieri, M., Carson, B. S., Khan, A., Penno, M., and Jallo, G. I. (2005) Flexible versus rigid catheters for chronic administration of exogenous agents into central nervous system tissues. J Neurosci Meth (Jun 15) 144(2), 147-152
20. Morrison, P. F., Chen, M. Y., Chadwick, R. S., Lonser, R. R., and Oldfield, E. H. (1999) Focal delivery during direct infusion to brain: role of flow rate, catheter diameter, and tissue mechanics. Am J Physiol (Oct) 277(4 Pt 2), R1218-R29.
21. Chen, M. Y., Lonser, R. R.,Morrison, P. F., Governale, L. S., andOldfield, E. H. (1999) Variables affecting convection-enhanced delivery to the striatum: a systematic examination of rate of infusion, cannula size, infusate concentration, and tissue-cannula sealing time. J Neurosurg (Feb) 90(2), 315-320
22. Morrison, P. F., Laske, D. W., Bobo, H., Oldfield, E. H., and Dedrick, R. L. (1994) High-flow microinfusion: tissue penetration and pharmacodynamics. Am J Physiol (Jan) 266(1 Pt 2), R292-R305.
23. Krauze, M. T., Saito, R., Noble, C. et al (2005) Reflux-free cannula for convectionenhanced high-speed delivery of therapeutic agents. J Neurosurg (Nov) 103(5), 923-929
24. Olson, J. J., Zhang, Z., Dillehay, D., and Stubbs, J. (2008) Assessment of a balloontipped catheter modified for intracerebral convection-enhanced delivery. J Neurooncol (Sep) 89(2), 159-168
25. Barth, R. F., Soloway, A. H., and Fairchild, R. G. (1990) Boron neutron capture therapy of cancer. Cancer Res (Feb 15) 50(4), 1061-1070
26. Yang, W., Barth, R. F., Adams, D. M. et al (2002) Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas. Cancer Res (Nov 15) 62(22), 6552-6558 (Pubitemid 35364121)
27. Cunningham, J., Oiwa, Y., Nagy, D., Podsakoff, G., Colosi, P., and Bankiewicz, K. S. (2000) Distribution of AAV-TK following intracranial convection-enhanced delivery into rats. Cell Transplant (Sep-Oct) 9(5), 585-594
28. Saito, R., Krauze, M. T., Noble, C. O. et al (2006) Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model. Neuro Oncol (Jul) 8(3), 205-214
29. Noble, C. O., Krauze, M. T., Drummond, D. C. et al (2006) Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy. Cancer Res (Mar 1) 66(5), 2801-2806
30. Saito, R., Bringas, J. R., Panner, A. et al (2004) Convection-enhanced delivery of tumor necrosis factor-related apoptosisinducing ligand with systemic administration of temozolomide prolongs survival in an intracranial glioblastoma xenograft model. Cancer Res (Oct 1) 64(19), 6858-6862
31. Degen, J. W., Walbridge, S., Vortmeyer, A. O., Oldfield, E. H., and Lonser, R. R. (2003) Safety and efficacy of convectionenhanced delivery of gemcitabine or carboplatin in a malignant glioma model in rats. J Neurosurg (Nov) 99(5), 893-898
32. Lidar, Z., Mardor, Y., Jonas, T. et al (2004) Convection-enhanced delivery of paclitaxel for the treatment of recurrent malignant glioma: a phase I/II clinical study. J Neurosurg (Mar) 100(3), 472-479
33. Jennings, M. T. and Pietenpol, J. A. (1998) The role of transforming growth factor beta in glioma progression. J Neurooncol (Jan) 36(2), 123-140
34. Frankel, B., Longo, S. L., and Ryken, T. C. (1999) Human astrocytomas co-expressing Fas and Fas ligand also produce TGFbeta2 and Bcl-2. J Neurooncol 44(3), 205-212
35. Kjellman, C., Olofsson, S. P., Hansson, O. et al (2000) Expression of TGF-beta isoforms, TGF-beta receptors, and SMAD molecules at different stages of human glioma. Int J Cancer (May 20) 89(3), 251-258
36. Schlingensiepen, R., Goldbrunner, M., Szyrach, M. N. et al (2005) Intracerebral and intrathecal infusion of the TGF-beta 2-specific antisense phosphorothioate oligonucleotide AP 12009 in rabbits and primates: toxicology and safety. Oligonucleotides (Summer) 15(2), 94-104.
37. Hau, P., Jachimczak, P., Schlingensiepen, R. et al (2007) Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies. Oligonucleotides (Summer) 17(2), 201-212
38. Patel, S. J., Shapiro, W. R., Laske, D. W. et al (2005) Safety and feasibility of convectionenhanced delivery of Cotara for the treatment of malignant glioma: initial experience in 51 patients. Neurosurgery (Jun) 56(6), 1243-1252 (discussion 1252-1253).
39. Laske, D. W., Youle, R. J., and Oldfield, E. H. (1997) Tumor regression with regional distribution of the targeted toxin TFCRM107 in patients with malignant brain tumors. Nat Med (Dec) 3(12), 1362-1368
40. Weaver, M. and Laske, D. W. (2003) Transferrin receptor ligand-targeted toxin conjugate (Tf-CRM107) for therapy of malignant gliomas. J Neurooncol (Oct) 65(1), 3-13.
41. Rand, R. W., Kreitman, R. J., Patronas, N., Varricchio, F., Pastan, I., and Puri, R. K. (2000) Intratumoral administration of recombinant circularly permuted interleukin-4-Pseudomonas exotoxin in patients with high-grade glioma. Clin Cancer Res (Jun) 6(6), 2157-2165
42. Weber, F., Asher, A., Bucholz, R. et al (2003) Safety, tolerability, and tumor response of IL4-Pseudomonas exotoxin (NBI-3001) in patients with recurrent malignant glioma. J Neurooncol (Aug-Sep) 64(1-2), 125-137
43. Brem, H., Piantadosi, S., Burger, P. C. et al (1995) Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. The Polymerbrain Tumor Treatment Group. Lancet (Apr 22) 345(8956), 1008-1012
44. Rainov, N. G. and Heidecke, V. (2004) Long term survival in a patient with recurrent malignant glioma treated with intratumoral infusion of an IL4-targeted toxin (NBI-3001). J Neurooncol (Jan) 66(1-2), 197-201.
45. Debinski, W., Obiri, N. I., Powers, S. K., Pastan, I., and Puri, R. K. (1995) Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin. Clin Cancer Res (Nov) 1(11), 1253-1258
46. Debinski, W., Gibo, D. M., Hulet, S. W., Connor, J. R., and Gillespie, G. Y. (1999) Receptor for interleukin 13 is a marker and therapeutic target for human high-grade gliomas. Clin Cancer Res (May) 5(5), 985-990 (Pubitemid 29233211)
47. Kunwar, S., Prados, M. D., Chang, S. M. et al (2007) Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group. J Clin Oncol (Mar 1) 25(7), 837-844
48. Vogelbaum, M. A., Sampson, J.H., Kunwar, S. et al (2007) Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results. Neurosurgery (Nov) 61(5), 1031-1037 (discussion 1037-1038).
49. Sawyer, A. J., Piepmeier, J.M., and Saltzman, W. M. (2006) Newmethods for direct delivery of chemotherapy for treating brain tumors. Yale J Biol Med (Dec) 79(3-4), 141-152
50. Wong, A. J., Bigner, S. H., Bigner, D. D., Kinzler, K. W., Hamilton, S. R., and Vogelstein, B. (1987) Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification. Proc Natl Acad Sci U S A (Oct) 84(19), 6899-6903
51. Sampson, J. H., Reardon, D. A., Friedman, A. H. et al (2005) Sustained radiographic and clinical response in patient with bifrontal recurrent glioblastoma multiforme with intracerebral infusion of the recombinant targeted toxin TP-38: case study. Neuro Oncol (Jan) 7(1), 90-96.
52. Sampson, J. H., Akabani, G., Archer, G. E. et al (2008) Intracerebral infusion of an EGFR-targeted toxin in recurrent malignant brain tumors. Neuro Oncol (Jun) 10(3), 320-329
53. Gregoriadis, G., Wills, E. J., Swain, C. P., and Tavill, A. S. (1974) Drug-carrier potential of liposomes in cancer chemotherapy. Lancet (Jun 29) 1(7870), 1313-1316
54. Harrington, K. J. (2001) Liposomal cancer chemotherapy: current clinical applications and future prospects. Expert Opin Investig Drugs (Jun) 10(6), 1045-1061
55. Maruyama,K. (2000) In vivo targeting by liposomes. Biol Pharm Bull (Jul) 23(7), 791-799
56. Voinea, M. and Simionescu, M. (2002) Designing of "intelligent" liposomes for efficient delivery of drugs. J Cell Mol Med (Oct-Dec) 6(4), 465-474
57. Moog, R., Burger, A. M., Brandl, M. et al (2002) Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels. Cancer Chemother Pharmacol (May) 49(5), 356-366
58. Zhu, J., Zhang, L., Hanisch, U. K., Felgner, P. L., and Reszka, R. (1996) A continuous intracerebral gene delivery system for in vivo liposome-mediated gene therapy. Gene Ther (Jun) 3(6), 472-476
59. von Eckardstein, K. L., Patt, S., Zhu, J., Zhang, L., Cervos-Navarro, J., and Reszka, R. (2001) Short-term neuropathological aspects of in vivo suicide gene transfer to the F98 rat glioblastoma using liposomal and viral vectors. Histol Histopathol (Jul) 16(3), 735-744
60. Park, J. W., Hong, K., Kirpotin, D. B., Meyer, O., Papahadjopoulos, D., and Benz, C. C. (1997) Anti-HER2 immunoliposomes for targeted therapy of human tumors. Cancer Lett (Oct) 14 118(2), 153-160
61. Park, J. W., Hong, K., Kirpotin, D. B., Papahadjopoulos, D., and Benz, C. C. (1997) Immunoliposomes for cancer treatment. Adv Pharmacol 40, 399-435.
62. Ram, Z., Culver, K. W., Oshiro, E. M. et al (1997) Therapy of malignant brain tumors by intratumoral implantation of retroviral vector-producing cells. Nat Med (Dec) 3(12), 1354-1361
63. Klatzmann, D., Valery, C. A., Bensimon, G. et al (1998) A phase I/II study of herpes simplex virus type 1 thymidine kinase "suicide" gene therapy for recurrent glioblastoma. Study Group on Gene Therapy for Glioblastoma. Hum Gene Ther (Nov 20) 9(17), 2595-2604
64. Shand, N., Weber, F., Mariani, L. et al (1999) A phase 1-2 clinical trial of gene therapy for recurrent glioblastoma multiforme by tumor transduction with the herpes simplex thymidine kinase gene followed by ganciclovir. GLI328 European-Canadian Study Group. Hum Gene Ther (Sep 20) 10(14), 2325-2335
65. Rainov, N. G. (2000) A phase III clinical evaluation of herpes simplex virus type 1 thymidine kinase and ganciclovir gene therapy as an adjuvant to surgical resection and radiation in adults with previously untreated glioblastoma multiforme. Hum Gene Ther (Nov 20) 11(17), 2389-2401
66. Voges, J., Reszka, R., Gossmann, A. et al (2003) Imaging-guided convectionenhanced delivery and gene therapy of glioblastoma. Ann Neurol (Oct) 54(4), 479-487
67. Chenevert, T. L.,McKeever, P. E., and Ross, B. D. (1997) Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res (Sep) 3(9), 1457-1466
68. Chinnaiyan, A. M., Prasad, U., Shankar, S. et al (2000) Combined effect of tumor necrosis factor-related apoptosis-inducing ligand and ionizing radiation in breast cancer therapy. Proc Natl Acad Sci U S A (Feb 15) 97(4), 1754-1759
69. Gupta, R. K., Sinha, U., Cloughesy, T. F., and Alger, J. R. (1999) Inverse correlation between choline magnetic resonance spectroscopy signal intensity and the apparent diffusion coefficient in human glioma. Magn Reson Med (Jan) 41(1), 2-7.
70. Chenevert, T. L., Stegman, L. D., Taylor, J. M. et al (2000) Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst (Dec 20) 92(24), 2029-2036.
71. Geschwind, J. F., Artemov, D., Abraham, S. et al (2000) Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Interv Radiol (Nov-Dec) 11(10), 1245-1255.
72. Pilatus, U., Shim, H., Artemov, D., Davis, D., van Zijl, P. C., and Glickson, J. D. (1997) Intracellular volume and apparent diffusion constants of perfused cancer cell cultures, as measured by NMR. Magn Reson Med (Jun) 37(6), 825-832.
73. Van Zijl, P. C., Moonen, C. T., Faustino, P., Pekar, J., Kaplan, O., and Cohen, J. S. (1991) Complete separation of intracellular and extracellular information in NMR spectra of perfused cells by diffusion-weighted spectroscopy. Proc Natl Acad SciUS A(Apr 15) 88(8), 3228-3232.
74. Mardor, Y., Roth, Y., Lidar, Z. et al (2001) Monitoring response to convectionenhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res (Jul 1) 61(13), 4971-4973.
75. Sampson, J. H., Raghavan, R., Provenzale, J. M. et al (2007) Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin. AJR Am J Roentgenol (Mar) 188(3), 703-709.
76. Edelman, R. R., Mattle, H. P., Atkinson, D. J. et al (1990) Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T. Radiology (Jul) 176(1), 211-220.
77. Rempp, K. A., Brix, G., Wenz, F., Becker, C. R., Guckel, F., and Lorenz, W. J. (1994) Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology (Dec) 193(3), 637-641. (Pubitemid 24366927)
78. Lonser, R. R., Warren, K. E., Butman, J. A. et al (2007) Real-time image-guided direct convective perfusion of intrinsic brainstem lesions. Technical note. J Neurosurg (Jul) 107(1), 190-197.
79. Mardor, Y., Rahav, O., Zauberman, Y. et al (2005) Convection-enhanced drug delivery: increased efficacy and magnetic resonance image monitoring. Cancer Res (Aug 1) 65(15), 6858-6863.
80. Murad, G. J., Walbridge, S., Morrison, P. F. et al (2007) Image-guided convectionenhanced delivery of gemcitabine to the brainstem. J Neurosurg (Feb) 106(2), 351-356.
81. Nguyen, T. T., Pannu, Y. S., Sung, C. et al (2003) Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging. J Neurosurg (Mar) 98(3), 584-590.
82. Wang, S. C., White, D. L., Pope, J. M., and Brasch, R. C. (1990) Magnetic resonance imaging contrast enhancement versus tissue gadolinium concentration. Invest Radiol (Sep) 25(Suppl 1), S44-45.
83. Lonser, R. R., Walbridge, S., Garmestani, K. et al (2002) Successful and safe perfusion of the primate brainstem: in vivo magnetic resonance imaging of macromolecular distribution during infusion. J Neurosurg (Oct) 97(4), 905-913.
84. Sampson, J. H., Brady, M. L., Petry, N. A. et al (2007) Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning. Neurosurgery (Feb) 60(2 Suppl 1) ONS89-98; discussion ONS98-89.
85. Saito, R., Bringas, J. R., McKnight, T. R. et al (2004) Distribution of liposomes into brain and rat brain tumor models by convection-enhanced delivery monitored with magnetic resonance imaging. Cancer Res (Apr 1) 64(7), 2572-2579.
86. Saito, R., Krauze, M. T., Bringas, J. R. et al (2005) Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain. Exp Neurol (Dec) 196(2), 381-389. (Pubitemid 41607827)
87. Murad, G. J., Walbridge, S., Morrison, P. F. et al (2006) Real-time, image-guided, convection-enhanced delivery of interleukin 13 bound to pseudomonas exotoxin. Clin Cancer Res (May 15) 12(10), 3145-3151.
88. Sampson, J. H., Raghavan, R., Brady, M. L. et al (2007) Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions. Neuro Oncol (Jul) 9(3), 343-353.